|
|
||||||||




Departments of
*
Pharmacology,
Biochemistry, and
Microbiology, University of Washington, Seattle, WA 98195
To define how the signaling pathways that mediate the B cell receptor (BCR) death pathway differ from those responsible for CD95/Fas-mediated death, we compared the BCR and Fas death pathways in two human B cell lines, B104 and BJAB. Both BCR- and Fas-induced apoptosis are blocked by the peptide cysteine protease inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (ZVAD (mlz)), demonstrating a common requirement caspase activity. Despite this common characteristic, the ability of actinomycin D and cycloheximide to block BCR-induced apoptosis, but not apoptosis induced by Fas cross-linking, suggests that a major difference between these two pathways is their differential requirements for new gene and protein synthesis. BCR- and Fas-mediated apoptosis are both accompanied by activation of stress-activated protein kinase and p38 mitogen-activated protein kinase (MAPK). Activation of both stress-activated protein kinase and p38 MAPK was inhibited by ZVAD (mlz), suggesting the involvement of caspases. To determine the role of p38 MAPK activation in BCR- and Fas-induced apoptosis, we employed SB203580, a specific inhibitor of p38 MAPK. SB203580 inhibited BCR-induced apoptosis, but not apoptosis induced by cross-linking Fas. Furthermore, both actinomycin D and SB203580 inhibited BCR-induced, but not Fas-induced, activation of caspase. Collectively, these findings establish a role for p38 MAPK in BCR-induced apoptosis both upstream and downstream of caspase activity. The p38 MAPK pathway may function to regulate transcriptional or translational events that are critical for BCR-induced apoptosis.
This article has been cited by other articles:
![]() |
Y. Xing, H. Igarashi, X. Wang, and N. Sakaguchi Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis J. Exp. Med., September 6, 2005; 202(5): 707 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petlickovski, L. Laurenti, X. Li, S. Marietti, P. Chiusolo, S. Sica, G. Leone, and D. G. Efremov Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells Blood, June 15, 2005; 105(12): 4820 - 4827. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bertho, V. M. Blancheteau, N. Setterblad, B. Laupeze, J. M. Lord, B. Drenou, L. Amiot, D. J. Charron, R. Fauchet, and N. Mooney MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-{delta} isoenzyme Int. Immunol., August 1, 2002; 14(8): 935 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Pedersen, A. M. Buhl, P. Klausen, C. H. Geisler, and J. Jurlander The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism Blood, February 15, 2002; 99(4): 1314 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Wu, C. Venkataraman, S. Estus, C. Dong, R. J. Davis, R. A. Flavell, and S. Bondada Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation J. Immunol., August 1, 2001; 167(3): 1263 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Yankee, K. E. Draves, M. K. Ewings, E. A. Clark, and J. D. Graves CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling PNAS, June 5, 2001; 98(12): 6789 - 6793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jiang and E. A. Clark Involvement of Bik, a Proapoptotic Member of the Bcl-2 Family, in Surface IgM-Mediated B Cell Apoptosis J. Immunol., May 15, 2001; 166(10): 6025 - 6033. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tian, C.-H. G. Chou, and A. L. DeFranco Apoptosis induced by the antigen receptor and Fas in a variant of the immature B cell line WEHI-231 and in splenic immature B cells Int. Immunol., April 1, 2001; 13(4): 581 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Richards, S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen J. Immunol., March 15, 2001; 166(6): 3855 - 3864. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takada, H. Toyota, J. Suzuki, and J. Mizuguchi Prevention of Anti-IgM-Induced Apoptosis Accompanying G1 Arrest in B Lymphoma Cells Overexpressing Dominant-Negative Mutant Form of c-Jun N-Terminal Kinase 1 J. Immunol., February 1, 2001; 166(3): 1641 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cho, J. Graves, and M. A. Reidy Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2527 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Riccioli, D. Starace, A. D'Alessio, G. Starace, F. Padula, P. De Cesaris, A. Filippini, and E. Ziparo TNF-{alpha} and IFN-{gamma} Regulate Expression and Function of the Fas System in the Seminiferous Epithelium J. Immunol., July 15, 2000; 165(2): 743 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aicher, M. Hayden-Ledbetter, W. A. Brady, A. Pezzutto, G. Richter, D. Magaletti, S. Buckwalter, J. A. Ledbetter, and E. A. Clark Characterization of Human Inducible Costimulator Ligand Expression and Function J. Immunol., May 1, 2000; 164(9): 4689 - 4696. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Swart, D. M. Bergeron, and T. C. Chiles Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas J. Immunol., March 1, 2000; 164(5): 2311 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aicher, G. L. Shu, D. Magaletti, T. Mulvania, A. Pezzutto, A. Craxton, and E. A. Clark Differential Role for p38 Mitogen-Activated Protein Kinase in Regulating CD40-Induced Gene Expression in Dendritic Cells and B Cells J. Immunol., December 1, 1999; 163(11): 5786 - 5795. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karas, T. Z. Zaks, L. JL, and D. LeRoith T Cell Receptor-induced Activation and Apoptosis In Cycling Human T Cells Occur throughout the Cell Cycle Mol. Biol. Cell, December 1, 1999; 10(12): 4441 - 4450. [Abstract] [Full Text] |
||||
![]() |
M. Berard, P. Mondiere, M. Casamayor-Palleja, A. Hennino, C. Bella, and T. Defrance Mitochondria Connects the Antigen Receptor to Effector Caspases During B Cell Receptor-Induced Apoptosis in Normal Human B Cells J. Immunol., November 1, 1999; 163(9): 4655 - 4662. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cutrona, N. Leanza, M. Ulivi, G. Melioli, V. L. Burgio, G. Mazzarello, G. Gabutti, S. Roncella, and M. Ferrarini Expression of CD10 by Human T Cells That Undergo Apoptosis Both In Vitro and In Vivo Blood, November 1, 1999; 94(9): 3067 - 3076. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drenou, V. Blancheteau, D. H. Burgess, R. Fauchet, D. J. Charron, and N. A. Mooney A Caspase-Independent Pathway of MHC Class II Antigen-Mediated Apoptosis of Human B Lymphocytes J. Immunol., October 15, 1999; 163(8): 4115 - 4124. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, H.-G. Wang, S. M. Srinivasula, E. S. Alnemri, and N. R. Cooper B Cell Apoptosis Triggered by Antigen Receptor Ligation Proceeds Via a Novel Caspase-Dependent Pathway J. Immunol., September 1, 1999; 163(5): 2483 - 2491. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Singh, P. Dhawan, C. Golden, G. S. Kapoor, and K. D. Mehta One-way Cross-talk between p38MAPK and p42/44MAPK. INHIBITION OF p38MAPK INDUCES LOW DENSITY LIPOPROTEIN RECEPTOR EXPRESSION THROUGH ACTIVATION OF THE p42/44MAPK CASCADE J. Biol. Chem., July 9, 1999; 274(28): 19593 - 19600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jiang, A. Craxton, T. Kurosaki, and E. A. Clark Different Protein Tyrosine Kinases Are Required for B Cell Antigen Receptor-mediated Activation of Extracellular Signal-Regulated kinase, c-Jun NH2-terminal Kinase 1, and p38 Mitogen-activated Protein Kinase J. Exp. Med., October 5, 1998; 188(7): 1297 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Craxton, G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark p38 MAPK Is Required for CD40-Induced Gene Expression and Proliferation in B Lymphocytes J. Immunol., October 1, 1998; 161(7): 3225 - 3236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Y. Cao, F. Shinjo, S. Heinrichs, J.-W. Soh, J. Jongstra-Bilen, and J. Jongstra Inhibition of Anti-IgM-induced Translocation of Protein Kinase C beta I Inhibits ERK2 Activation and Increases Apoptosis J. Biol. Chem., June 29, 2001; 276(27): 24506 - 24510. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Marches, E. S. Vitetta, and J. W. Uhr A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas PNAS, March 13, 2001; 98(6): 3434 - 3439. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |